beryllium sulfate has been researched along with Chronic Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elliott, J; Gillespie, M; Gottschall, EB; Hamzeh, N; Li, L; Maier, LA; Mroz, PM; Wang, J | 1 |
| Canavera, SJ; Fontenot, AP; Gharavi, L; Kotzin, BL; Newman, LS | 1 |
| Williams, WJ; Williams, WR | 2 |
| Newman, LS; Tinkle, SS | 1 |
| Galle, J; Greinert, U; Müller-Quernheim, J; Schlaak, M; Schreiber, J; Schulz, KH; Zissel, G | 1 |
| Kittle, LA; Newman, LS; Tinkle, SS | 1 |
| Fontenot, AP; Kotzin, BL; Marshall, WH; Newman, LS; Torres, M | 1 |
8 other study(ies) available for beryllium sulfate and Chronic Disease
| Article | Year |
|---|---|
Beryllium increases the CD14(dim)CD16+ subset in the lung of chronic beryllium disease.
Topics: Aged; Berylliosis; Beryllium; Bronchoalveolar Lavage Fluid; Chemokines; Chronic Disease; Cytokines; Female; HLA-DR Antigens; Humans; Leukocytes, Mononuclear; Lipopolysaccharide Receptors; Lung; Macrophages, Alveolar; Male; Middle Aged; Monocytes; Phagocytosis; Phenotype; Receptors, IgG | 2015 |
Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.
Topics: Berylliosis; Beryllium; Bronchoalveolar Lavage Fluid; CD4-Positive T-Lymphocytes; Chronic Disease; Cytokines; Female; Humans; Immunologic Memory; In Vitro Techniques; Lymphocyte Activation; Male; Middle Aged; Organ Specificity; Th1 Cells | 2002 |
Value of beryllium lymphocyte transformation tests in chronic beryllium disease and in potentially exposed workers.
Topics: Adult; Aged; Berylliosis; Beryllium; Chronic Disease; Environmental Exposure; Female; Humans; Lymphocyte Activation; Male; Middle Aged | 1983 |
Development of beryllium lymphocyte transformation tests in chronic beryllium disease.
Topics: Berylliosis; Beryllium; Cell Separation; Cells, Cultured; Chronic Disease; Humans; Lymphocyte Activation; Phytohemagglutinins; Tuberculin; Tuberculin Test | 1982 |
Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease.
Topics: Adult; Berylliosis; Beryllium; Bronchoalveolar Lavage Fluid; Chronic Disease; Female; Forced Expiratory Volume; Humans; Hypersensitivity; Interleukin-6; Male; Middle Aged; Pulmonary Gas Exchange; Receptors, Interleukin-6; Receptors, Tumor Necrosis Factor; Solubility; Tumor Necrosis Factor-alpha; Vital Capacity | 1997 |
[Diagnosis of chronic berylliosis].
Topics: Adult; Berylliosis; Beryllium; Chronic Disease; Female; Humans; Intradermal Tests; Lymphocyte Activation; Male; Middle Aged; Sensitivity and Specificity | 1999 |
Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
Topics: Adjuvants, Immunologic; Berylliosis; Beryllium; Bronchoalveolar Lavage Fluid; Cells, Cultured; Chronic Disease; Cytokines; Dose-Response Relationship, Immunologic; HLA-D Antigens; Humans; Immunity, Cellular; Immunosuppressive Agents; Interleukin-10; Lymphocyte Activation; Macrophages, Alveolar; Recombinant Proteins; T-Lymphocytes | 1999 |
Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.
Topics: Alleles; Antigen Presentation; Berylliosis; Beryllium; CD4-Positive T-Lymphocytes; Cell Line, Transformed; Cells, Cultured; Chronic Disease; Disease Susceptibility; Genetic Predisposition to Disease; HLA-DP Antigens; HLA-DP beta-Chains; HLA-DQ Antigens; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Lung | 2000 |